Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.
about
Beyond Dose: Using Pretherapy Biomarkers to Improve Dose Prediction of Outcomes for Radioimmunotherapy of Non-Hodgkin Lymphoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Beyond Dose: Using Pretherapy ...... erapy of Non-Hodgkin Lymphoma.
@en
Beyond Dose: Using Pretherapy ...... erapy of Non-Hodgkin Lymphoma.
@nl
type
label
Beyond Dose: Using Pretherapy ...... erapy of Non-Hodgkin Lymphoma.
@en
Beyond Dose: Using Pretherapy ...... erapy of Non-Hodgkin Lymphoma.
@nl
prefLabel
Beyond Dose: Using Pretherapy ...... erapy of Non-Hodgkin Lymphoma.
@en
Beyond Dose: Using Pretherapy ...... erapy of Non-Hodgkin Lymphoma.
@nl
P2093
P2860
P356
P1476
Beyond Dose: Using Pretherapy ...... erapy of Non-Hodgkin Lymphoma.
@en
P2093
Anca M Avram
Lauren B Smith
Mark S Kaminski
Matthew J Schipper
Meredith A Morgan
Peter L Roberson
Scott J Wilderman
Yuni K Dewaraja
P2860
P304
P356
10.1089/CBR.2017.2182
P577
2017-10-30T00:00:00Z